PATENT CLAIM ANALYSIS

Application Number: 16359068
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "171000"]

Abstract:
The invention relates to compositions and formulations comprising at least one triterpenoic acid and at least one neutral triterpenoid and uses thereof for treating for use in treating a condition selected from Alzheimer's disease (AD), Parkinson's Diseases (PD) and vascular dementia (VD).

Claim (Index 1):
A method of treating a condition selected from Multi System Atrophy (MSA), Progressive Supranuclear Palsy (PSP), Parkinson-plus syndrome, Parkinsonisms, tauopathic diseases and conditions and Pick's disease, comprising administering to a subject in need thereof a pharmaceutical composition comprising a combination of at least one triterpenoic acid and at least one neutral triterpenoid, and a pharmaceutically acceptable carrier, wherein the triterpenoic acid is selected from masticadienonic acid (MDA), isomasticadienonic acid (IMDA) or both, wherein the neutral triterpenoid is selected from (8R)-3-beta-8-dihydroxypolypoda-13E,17E,21-triene (NF-1), (8R)-3-Oxo-8-hydroxypolypoda-13E,17E,21-triene (NF-2) or both

Metadata:
- Claim Count in Document: 1.0
- Percentile: 99.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15761759', '15000849', '15677365', '13821194', '16190780']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7820787505362281
- 35 USC 102 Novelty (BERT): 0.7438555684099428
- Combined Prediction Score: 0.7782564323235995
- Mean Citation Score: 492.635106
- Max Citation Score: 985.73755
- Similarity Product: 825.2833761372923

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test